<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the implication of karyotype analysis in diagnosis and prognosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The chromosomes were prepared with direct method, brief culture of cells and R-banding techniques, and then the karyotypic analysis was performed </plain></SENT>
<SENT sid="2" pm="."><plain>RESULT: Seventy-seven out of 283 patients (27.21%) had karyotypic abnormalities, including the numeral abnormalities of chromosomes and structural alterations </plain></SENT>
<SENT sid="3" pm="."><plain>The most common chromosomal aberrations were +8, -20/20q-, -Y, translocation, -7/7q-, +9, -5/5q- </plain></SENT>
<SENT sid="4" pm="."><plain>The rate of abnormal karyotype in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with erythroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> erythroblasts-transformation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-t) was much higher than in <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> (RA) </plain></SENT>
<SENT sid="5" pm="."><plain>Patients with abnormal karyotype or higher IPSS scores had a higher risk of transformation into <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> than patients with <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype or lower IPSS scores (P&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> is a highly heterogenous disorder and karyotype analysis is helpful for its diagnosis and prognosis estimation </plain></SENT>
</text></document>